CN105194740B - A kind of post-operation adhesion preventing hydrogel and preparation method thereof - Google Patents
A kind of post-operation adhesion preventing hydrogel and preparation method thereof Download PDFInfo
- Publication number
- CN105194740B CN105194740B CN201510598128.7A CN201510598128A CN105194740B CN 105194740 B CN105194740 B CN 105194740B CN 201510598128 A CN201510598128 A CN 201510598128A CN 105194740 B CN105194740 B CN 105194740B
- Authority
- CN
- China
- Prior art keywords
- mass ratio
- powder
- acrylamide monomer
- sodium alginate
- chitosan
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000017 hydrogel Substances 0.000 title claims abstract description 59
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 claims abstract description 72
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims abstract description 51
- 229920001661 Chitosan Polymers 0.000 claims abstract description 51
- 235000010413 sodium alginate Nutrition 0.000 claims abstract description 51
- 239000000661 sodium alginate Substances 0.000 claims abstract description 51
- 229940005550 sodium alginate Drugs 0.000 claims abstract description 51
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 claims abstract description 50
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 claims abstract description 36
- 239000000843 powder Substances 0.000 claims abstract description 33
- 229910001870 ammonium persulfate Inorganic materials 0.000 claims abstract description 25
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 claims abstract description 23
- 239000000463 material Substances 0.000 claims abstract description 21
- ZIUHHBKFKCYYJD-UHFFFAOYSA-N n,n'-methylenebisacrylamide Chemical compound C=CC(=O)NCNC(=O)C=C ZIUHHBKFKCYYJD-UHFFFAOYSA-N 0.000 claims abstract description 15
- 238000000034 method Methods 0.000 claims abstract description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 49
- 239000000243 solution Substances 0.000 claims description 38
- 239000011259 mixed solution Substances 0.000 claims description 22
- 238000003756 stirring Methods 0.000 claims description 17
- 239000011812 mixed powder Substances 0.000 claims description 16
- 239000003431 cross linking reagent Substances 0.000 claims description 14
- 239000007864 aqueous solution Substances 0.000 claims description 12
- 239000000178 monomer Substances 0.000 claims description 11
- 239000003054 catalyst Substances 0.000 claims description 9
- 238000006243 chemical reaction Methods 0.000 claims description 8
- 238000004132 cross linking Methods 0.000 claims description 8
- 150000001768 cations Chemical class 0.000 claims description 7
- 239000000499 gel Substances 0.000 claims description 7
- 239000011521 glass Substances 0.000 claims description 7
- 230000006196 deacetylation Effects 0.000 claims description 4
- 238000003381 deacetylation reaction Methods 0.000 claims description 4
- -1 propylene Amide Chemical class 0.000 claims description 2
- 210000000481 breast Anatomy 0.000 claims 1
- 150000004676 glycans Chemical class 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 claims 1
- 230000002980 postoperative effect Effects 0.000 abstract description 10
- 206010052428 Wound Diseases 0.000 abstract description 9
- 208000027418 Wounds and injury Diseases 0.000 abstract description 9
- 239000002131 composite material Substances 0.000 abstract description 9
- 239000012620 biological material Substances 0.000 abstract description 3
- 231100000252 nontoxic Toxicity 0.000 abstract description 3
- 230000003000 nontoxic effect Effects 0.000 abstract description 3
- 208000000860 Compassion Fatigue Diseases 0.000 abstract description 2
- 230000000474 nursing effect Effects 0.000 abstract description 2
- 239000002904 solvent Substances 0.000 abstract description 2
- 229960000583 acetic acid Drugs 0.000 description 16
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 8
- 239000012362 glacial acetic acid Substances 0.000 description 5
- 238000001356 surgical procedure Methods 0.000 description 5
- 238000009864 tensile test Methods 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 4
- 206010060932 Postoperative adhesion Diseases 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 239000011575 calcium Substances 0.000 description 4
- 229910052791 calcium Inorganic materials 0.000 description 4
- 230000035876 healing Effects 0.000 description 4
- 230000023597 hemostasis Effects 0.000 description 4
- 229920000747 poly(lactic acid) Polymers 0.000 description 4
- 239000004626 polylactic acid Substances 0.000 description 4
- 230000002378 acidificating effect Effects 0.000 description 3
- 238000006731 degradation reaction Methods 0.000 description 3
- 210000000416 exudates and transudate Anatomy 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 208000031737 Tissue Adhesions Diseases 0.000 description 2
- 230000009102 absorption Effects 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 210000002808 connective tissue Anatomy 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 229920002401 polyacrylamide Polymers 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 208000007984 Female Infertility Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010021928 Infertility female Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000030714 Recurrent Laryngeal Nerve injury Diseases 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 238000012084 abdominal surgery Methods 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000007872 degassing Methods 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 208000008384 ileus Diseases 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000004197 pelvis Anatomy 0.000 description 1
- JRKICGRDRMAZLK-UHFFFAOYSA-L peroxydisulfate Chemical compound [O-]S(=O)(=O)OOS([O-])(=O)=O JRKICGRDRMAZLK-UHFFFAOYSA-L 0.000 description 1
- 230000010118 platelet activation Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Materials For Medical Uses (AREA)
Abstract
本发明公开了一种术后防粘连水凝胶及其制备方法,所述水凝胶由海藻酸钠粉末、壳聚糖粉末、丙烯酰胺单体、N,N’‑亚甲基双丙烯酰胺、硫酸钙、过硫酸胺和N,N,N’N’‑四甲基乙二胺制备而成。本发明提供了一种高强、高韧性壳聚糖与海藻酸钠复合水凝胶的制备方法,该制备方法易于操作,参数可控,材料易得,溶剂无毒或低毒,处理和使用安全;该方法集结了两种天然生物材料的优点,能够很好的满足预防患者术后防粘连的要求,及医护人员的护理治疗需求。该水凝胶柔软易于与皮肤贴合,具有良好的柔韧性,可以有效防止创面粘连,并能够被降解吸收,避免二次创伤的产生,有望成为新型术后防粘连材料。The invention discloses a postoperative anti-adhesion hydrogel and a preparation method thereof. The hydrogel is composed of sodium alginate powder, chitosan powder, acrylamide monomer, N,N'-methylenebisacrylamide , calcium sulfate, ammonium persulfate and N,N,N'N'-tetramethylethylenediamine. The invention provides a preparation method of a high-strength, high-toughness chitosan and sodium alginate composite hydrogel, the preparation method is easy to operate, the parameters are controllable, the material is easy to obtain, the solvent is non-toxic or low-toxic, and it is safe to handle and use ; This method combines the advantages of two natural biological materials, which can well meet the requirements of preventing postoperative anti-adhesion of patients and the nursing and treatment needs of medical staff. The hydrogel is soft and easy to adhere to the skin, has good flexibility, can effectively prevent wound adhesion, and can be degraded and absorbed to avoid secondary trauma. It is expected to become a new type of postoperative anti-adhesion material.
Description
技术领域technical field
本发明属于生物医用材料技术领域,涉及一种具有术后防粘连、抗菌、止血、愈创作用的医用水凝胶及其制备方法。The invention belongs to the technical field of biomedical materials, and relates to a medical hydrogel with postoperative anti-adhesion, antibacterial, hemostatic and healing functions and a preparation method thereof.
背景技术Background technique
手术后粘连是有手术史以来国内外亟待解决的重要医学难题之一。在外科领域开展的手术中,绝大多数都涉及到防止组织之间粘连的问题,粘连发生不仅会给患者带来痛苦而且需面临高额的手术开销,因此开发预防粘连材料刻不容缓。在正常情况下,结缔组织的纤维带是不会与相邻的器官或组织粘在一起,但经手术后,因手术创伤、伤口局部缺血、异物存在、出血和暴露伤口表面及细菌感染而出现结缔组织纤维带与相邻组织或器官粘在一起的异常结构,也是在外科领域常见的临床现象—粘连。手术后粘连可以引起严重的并发症,如腹部、盆腔等均可引起粘连性肠梗阻,甲状腺手术后引起喉返神经损伤以及因盆腔组织粘连而导致的女性不育症。其中,做过腹腔手术的患者约有93%会有粘连发生,而经历过妇科手术的患者粘连的发生率高达97%(不孕妇女中40%是由粘连引起的)。因此,如何有效预防术后粘连来降低临床并发症的发生率是临床治疗中亟待解决的重要课题。Postoperative adhesion is one of the important medical problems to be solved urgently at home and abroad since the history of surgery. Most of the operations in the surgical field involve the prevention of adhesion between tissues. The occurrence of adhesion will not only bring pain to patients but also face high surgical expenses. Therefore, it is urgent to develop adhesion prevention materials. Under normal circumstances, the fibrous bands of connective tissue will not stick together with adjacent organs or tissues, but after surgery, due to surgical trauma, wound ischemia, foreign body presence, bleeding and exposed wound surface and bacterial infection Abnormal structures in which fibrous bands of connective tissue stick together with adjacent tissues or organs are also common clinical phenomena in the field of surgery—adhesions. Postoperative adhesions can cause serious complications, such as adhesive ileus in the abdomen and pelvis, recurrent laryngeal nerve injury after thyroid surgery, and female infertility caused by pelvic tissue adhesions. Among them, about 93% of patients who have undergone abdominal surgery will have adhesions, and the incidence of adhesions in patients who have undergone gynecological surgery is as high as 97% (40% of infertile women are caused by adhesions). Therefore, how to effectively prevent postoperative adhesions to reduce the incidence of clinical complications is an important issue to be solved in clinical treatment.
目前临床上应用较多的防术后粘连材料主要有凝胶类和聚乳酸类两种:凝胶类(透明质酸钠和壳聚糖凝胶)在体内能够生物降解,但降解速率过快,体内保留时间过短而且凝胶容易流失,使得防粘连效果欠佳;聚乳酸类(左旋聚乳酸、消旋聚乳酸等)是目前在生物医学工程应用最多的材料,同时也是通过美国FDA认证的为数不多的几种生物材料之一,但是其在降解过程中会产生酸性降解产物,酸性物质一方面起自催化作用、加速母体的降解,减少了体内保留时间,降低了防粘连效果,另一方面大量酸性产物堆积,又可能产生非感染性炎症对组织和器官造成一定的刺激。海藻酸钠具有良好的生物相容性、生物可降解性、止血性等生物性能,目前作为防粘连材料的报道较少。理想的防粘连材料应具有良好的生物相容性、适宜的组织粘附性(不需缝合),能完全覆盖创伤表面并具有足够的体内存留时间;能够降解吸收而不需二次手术将其取出;起到有效防止粘连形成的作用,又可以不影响伤口的正常愈合过程;同时兼顾止血、抗菌、促愈的作用并有一定的机械强度及韧性,以便于手术中将材料植入等。At present, there are mainly two types of postoperative adhesion prevention materials used clinically: gel and polylactic acid: gel (sodium hyaluronate and chitosan gel) can biodegrade in vivo, but the degradation rate is too fast , the retention time in the body is too short and the gel is easy to lose, which makes the anti-adhesion effect poor; polylactic acid (L-polylactic acid, racemic polylactic acid, etc.) is currently the most widely used material in biomedical engineering, and it is also certified by the US FDA It is one of the few biological materials, but it will produce acidic degradation products during the degradation process. On the one hand, acidic substances play an autocatalytic role, accelerate the degradation of the matrix, reduce the retention time in the body, and reduce the anti-adhesion effect. On the other hand, the accumulation of a large amount of acidic products may cause non-infectious inflammation and cause certain irritation to tissues and organs. Sodium alginate has good biocompatibility, biodegradability, hemostasis and other biological properties, and there are few reports on it as an anti-adhesion material. An ideal anti-adhesion material should have good biocompatibility, suitable tissue adhesion (no sutures required), be able to completely cover the wound surface and have sufficient retention time in the body; it can be degraded and absorbed without secondary surgery. Take it out; it can effectively prevent the formation of adhesions without affecting the normal healing process of the wound; at the same time, it also has the functions of hemostasis, antibacterial, and healing promotion, and has certain mechanical strength and toughness, so that the material can be implanted during the operation.
在已有专利中,CN 103224679A公开了一种壳聚糖聚丙烯酰胺水凝胶基底材料,由丙烯酰胺、甲叉双丙烯酰胺、过硫酸铵、四甲基乙二胺、壳聚糖等溶液组成,得到不同硬度的水凝胶且具有无毒性作用,降低了研究细胞力学的复杂性。CN 104558420A公开了一种温度和pH敏感性羧甲基壳聚糖水凝胶,分别以过硫酸铵、N,N,N’,N’-四甲基乙二胺和N,N’-亚甲基双丙烯酰胺为引发剂、促进剂和交联剂,通过交联反应制得,使得其生物相容性有所提高,扩大了其应用范围。CN 103396562A公开了一种基于海藻酸钠-丙烯酰胺水凝胶的制备方法,以丙烯酰胺单体、甲叉双丙烯酰胺为交联剂,过硫酸铵和N,N,N’,N’-四甲基乙二胺为催化剂,得到高强度、高韧性的海藻酸钠水凝胶。Li等制备的海藻酸盐-聚丙烯酰胺水凝胶可以同时具备高强度和韧性,采用丙烯酰胺、N,N’-亚甲基双丙烯酰胺、CaSO4·2H2O和CaCl2作为交联剂,过硫酸铵和N,N,N’,N’-四甲基乙二胺为催化剂制得的水凝胶,在生物医用领域具有很好的应用前景。Among the existing patents, CN 103224679A discloses a chitosan polyacrylamide hydrogel base material, which is composed of acrylamide, methylene bisacrylamide, ammonium persulfate, tetramethylethylenediamine, chitosan and other solutions Composition, to obtain hydrogels with different hardness and non-toxic effects, which reduces the complexity of studying cell mechanics. CN 104558420A discloses a temperature- and pH-sensitive carboxymethyl chitosan hydrogel, which is composed of ammonium persulfate, N,N,N',N'-tetramethylethylenediamine and N,N'-methylene The base bisacrylamide is used as an initiator, an accelerator and a crosslinking agent, and is prepared through a crosslinking reaction, which improves its biocompatibility and expands its application range. CN 103396562A discloses a preparation method based on sodium alginate-acrylamide hydrogel, using acrylamide monomer and methylenebisacrylamide as crosslinking agent, ammonium persulfate and N,N,N',N'- Tetramethylethylenediamine is used as a catalyst to obtain sodium alginate hydrogel with high strength and high toughness. The alginate-polyacrylamide hydrogel prepared by Li et al. can have high strength and toughness at the same time, using acrylamide, N,N'-methylenebisacrylamide, CaSO 4 2H 2 O and CaCl 2 as crosslinks agent, ammonium persulfate and N,N,N',N'-tetramethylethylenediamine as catalysts, the hydrogel has a good application prospect in the field of biomedicine.
发明内容Contents of the invention
本发明综合现有材料以及提高水凝胶性能的制备方法,提供一种术后防粘连水凝胶及其制备方法,将壳聚糖与海藻酸钠进行复合制备出高强度和高韧性的水凝胶,有望成为具有抗菌、止血、吸收组织渗出液、保持创面湿润和有效促进创面愈合的术后防粘连材料。The present invention integrates the existing materials and the preparation method for improving the performance of the hydrogel, and provides a postoperative anti-adhesion hydrogel and a preparation method thereof. Chitosan and sodium alginate are compounded to prepare a water gel with high strength and high toughness. Gel is expected to become a postoperative anti-adhesion material with antibacterial, hemostasis, absorption of tissue exudate, maintenance of wound surface moisture and effective promotion of wound healing.
本发明的目的是通过以下技术方案实现的:The purpose of the present invention is achieved through the following technical solutions:
一种术后防粘连水凝胶,由海藻酸钠粉末、壳聚糖粉末、丙烯酰胺单体、N,N’-亚甲基双丙烯酰胺、硫酸钙、过硫酸胺和N,N, N’ N’-四甲基乙二胺制备而成,其中,壳聚糖粉末与海藻酸钠粉末的质量比为8-10:1-3,壳聚糖和海藻酸钠混合粉末与丙烯酰胺单体的质量比为1:3-20,N,N’-亚甲基双丙烯酰与丙烯酰胺单体的质量比为0.0006-0.0025,硫酸钙与丙烯酰胺单体的质量比为0.016,过硫酸铵与丙烯酰胺单体的质量比为0.006-0.03,N,N,N’,N’-四甲基乙二胺与丙烯酰胺单体的质量比为0.0025-0.0055。A postoperative anti-adhesion hydrogel composed of sodium alginate powder, chitosan powder, acrylamide monomer, N,N'-methylenebisacrylamide, calcium sulfate, ammonium persulfate and N,N,N 'N'-tetramethylethylenediamine, wherein the mass ratio of chitosan powder to sodium alginate powder is 8-10:1-3, chitosan and sodium alginate mixed powder and acrylamide mono The mass ratio of the body is 1:3-20, the mass ratio of N,N'-methylenebisacryloyl to acrylamide monomer is 0.0006-0.0025, the mass ratio of calcium sulfate to acrylamide monomer is 0.016, persulfate The mass ratio of ammonium to acrylamide monomer is 0.006-0.03, and the mass ratio of N,N,N',N'-tetramethylethylenediamine to acrylamide monomer is 0.0025-0.0055.
一种上述术后防粘连水凝胶的制备方法,具体步骤如下:A preparation method of the above-mentioned postoperative anti-adhesion hydrogel, the specific steps are as follows:
第一步:在室温条件下将壳聚糖和海藻酸钠混合粉末溶解在0.5-2w/v%醋酸水溶液中,用磁力搅拌器搅拌使其充分溶解,得到均一稳定的混合溶液;Step 1: Dissolve chitosan and sodium alginate mixed powder in 0.5-2w/v% acetic acid aqueous solution at room temperature, stir with a magnetic stirrer to fully dissolve, and obtain a uniform and stable mixed solution;
第二步:依次向第一步得到的混合溶液中加入丙烯酰胺单体,将混合溶液在室温下搅拌10-48h直至溶液溶解均匀;然后逐步加入N,N’-亚甲基双丙烯酰胺、硫酸钙作为交联剂,过硫酸胺和N,N, N’ N’-四甲基乙二胺作为催化剂,在室温下继续搅拌0.5-3h,将配制好的溶液在室温下静置0.5-2h脱泡;将静置好的溶液倒入玻璃模具中,在室温下静置6-10h确保其完全反应,得到水凝胶。The second step: add acrylamide monomer to the mixed solution obtained in the first step in sequence, and stir the mixed solution at room temperature for 10-48 hours until the solution is uniformly dissolved; then gradually add N,N'-methylenebisacrylamide, Calcium sulfate is used as a crosslinking agent, ammonium persulfate and N,N,N' N'-tetramethylethylenediamine are used as catalysts, and stirring is continued at room temperature for 0.5-3h, and the prepared solution is left to stand at room temperature for 0.5- Degassing for 2 hours; Pour the static solution into a glass mold, and let it stand at room temperature for 6-10 hours to ensure its complete reaction to obtain a hydrogel.
第三步:将第二步制备好的水凝胶完全浸泡在浓度为0.05-1.5M的CaCl2溶液中3-36h,阳离子扩散进入水凝胶网络结构中,诱导壳聚糖和海藻酸钠交联,制备出高强高韧性的复合水凝胶防粘连材料。The third step: The hydrogel prepared in the second step is completely soaked in the CaCl 2 solution with a concentration of 0.05-1.5M for 3-36h, the cations diffuse into the hydrogel network structure, and induce chitosan and sodium alginate Cross-linking to prepare a high-strength and high-toughness composite hydrogel anti-adhesion material.
优选地,所述第一步溶液中壳聚糖与海藻酸钠混合粉末的浓度为0.5-2%(w/w)。Preferably, the concentration of chitosan and sodium alginate mixed powder in the first step solution is 0.5-2% (w/w).
优选地,所述第一步中壳聚糖为乳白色粉末,脱乙酰度>70%,级别为医用级,海藻酸钠为白色粉末,级别为医用级。Preferably, in the first step, chitosan is a milky white powder with a degree of deacetylation>70%, and its grade is medical grade, and sodium alginate is a white powder, and its grade is medical grade.
与现有技术相比,本发明的有益效果是:Compared with prior art, the beneficial effect of the present invention is:
1、本发明提供了一种高强、高韧性壳聚糖与海藻酸钠复合水凝胶的制备方法,该制备方法易于操作,参数可控,材料易得,溶剂无毒或低毒,处理和使用安全;该方法集结了两种天然生物材料的优点,能够很好的满足预防患者术后防粘连的要求,及医护人员的护理治疗需求。1. The present invention provides a preparation method of high-strength, high-toughness chitosan and sodium alginate composite hydrogel, the preparation method is easy to operate, the parameters are controllable, the material is easy to obtain, the solvent is non-toxic or low-toxic, and the treatment and It is safe to use; this method integrates the advantages of two natural biological materials, and can well meet the requirements of preventing postoperative anti-adhesion of patients and the nursing and treatment needs of medical staff.
2、该方法制备的壳聚糖与海藻酸钠复合水凝胶具有高强高韧性特点,弥补了以往水凝胶的不足,壳聚糖本身具有广谱抗菌、止血、吸收渗出液、愈创,以及良好的生物相容性和生物可降解性,海藻酸钠当与创面渗液接触时,可通过离子交换制备出可溶性的海藻酸钠,同时释放钙离子到伤口中,诱导血小板活化,可以加速创面愈合。2. The chitosan and sodium alginate composite hydrogel prepared by this method has the characteristics of high strength and high toughness, which makes up for the shortcomings of previous hydrogels. Chitosan itself has broad-spectrum antibacterial, hemostasis, absorption of exudate, healing , as well as good biocompatibility and biodegradability, when sodium alginate is in contact with wound exudate, soluble sodium alginate can be prepared by ion exchange, and at the same time release calcium ions into the wound to induce platelet activation, which can Accelerates wound healing.
3、该水凝胶柔软易于与皮肤贴合,具有良好的柔韧性,可以有效防止创面粘连,并能够被降解吸收,避免二次创伤的产生,有望成为新型术后防粘连材料。3. The hydrogel is soft and easy to adhere to the skin, has good flexibility, can effectively prevent wound adhesion, and can be degraded and absorbed to avoid secondary trauma. It is expected to become a new type of postoperative anti-adhesion material.
具体实施方式Detailed ways
下面结合实施例对本发明的技术方案作进一步的说明,但并不局限于此,凡是对本发明技术方案进行修改或者等同替换,而不脱离本发明技术方案的精神和范围,均应涵盖在本发明的保护范围中。The technical solution of the present invention will be further described below in conjunction with the examples, but it is not limited thereto. Any modification or equivalent replacement of the technical solution of the present invention without departing from the spirit and scope of the technical solution of the present invention should be covered by the present invention within the scope of protection.
实施例1Example 1
(1)用电子天平分别称取一定量的冰醋酸,配成质量分数为0.5w/v%的醋酸水溶液,称取一定质量CS/SA(9/1)粉末加入到醋酸水溶液中,配置成0.5w/v%的混合溶液,用磁力搅拌器搅拌使其充分溶解,得到均一稳定的溶液。(1) Weigh a certain amount of glacial acetic acid with an electronic balance to make an acetic acid aqueous solution with a mass fraction of 0.5w/v%, weigh a certain mass of CS/SA (9/1) powder and add it to the acetic acid aqueous solution to prepare The mixed solution of 0.5w/v% was stirred with a magnetic stirrer to fully dissolve it to obtain a uniform and stable solution.
(2)依次向上述混合溶液中加入丙烯酰胺单体,将混合溶液在室温下搅拌2d直至溶液溶解均匀;然后逐步加入N,N’-亚甲基双丙烯酰、硫酸钙作为交联剂,过硫酸胺和N,N,N’ N’-四甲基乙二胺作为催化剂,在室温下继续搅拌1h,将配制好的溶液在室温下静置0.5-2h脱泡;将静置好的溶液倒入玻璃模具中,在室温下静置一晚上确保其完全反应。其中:壳聚糖和海藻酸钠混合粉末与丙烯酰胺单体的质量比为1:5,N,N’-亚甲基双丙烯酰交联剂与丙烯酰胺单体的质量比为0.0006,硫酸钙与丙烯酰胺单体的质量比为0.016,过硫酸铵与丙烯酰胺单体的质量比为0.006,N,N,N’,N’-四甲基乙二胺与丙烯酰胺单体的质量比为0.0025。(2) Add acrylamide monomers to the above mixed solution in sequence, and stir the mixed solution at room temperature for 2 days until the solution is uniformly dissolved; then gradually add N,N'-methylenebisacryloyl and calcium sulfate as cross-linking agents, Use ammonium persulfate and N,N,N' N'-tetramethylethylenediamine as a catalyst, continue to stir at room temperature for 1h, and leave the prepared solution at room temperature for 0.5-2h to defoam; The solution was poured into glass molds and left overnight at room temperature to ensure complete reaction. Among them: the mass ratio of chitosan and sodium alginate mixed powder to acrylamide monomer is 1:5, the mass ratio of N,N'-methylenebisacryloyl crosslinking agent to acrylamide monomer is 0.0006, sulfuric acid The mass ratio of calcium to acrylamide monomer is 0.016, the mass ratio of ammonium persulfate to acrylamide monomer is 0.006, and the mass ratio of N,N,N',N'-tetramethylethylenediamine to acrylamide monomer is 0.0025.
(3)将制备好的水凝胶完全浸泡在浓度为0.5M的CaCl2溶液中12h,阳离子扩散进入水凝胶网络结构中,诱导壳聚糖和海藻酸钠交联,生产高强高韧性的复合水凝胶防粘连材料。(3) The prepared hydrogel was completely soaked in 0.5M CaCl 2 solution for 12 hours, the cations diffused into the hydrogel network structure, induced the cross-linking of chitosan and sodium alginate, and produced high strength and high toughness Composite hydrogel anti-adhesion material.
对制得的水凝胶进行拉伸测试,得到拉伸强度为995.3kPa;拉伸弹性模量200kPa。A tensile test was performed on the prepared hydrogel to obtain a tensile strength of 995.3 kPa; a tensile modulus of elasticity of 200 kPa.
实施例2Example 2
(1)用电子天平分别称取一定量的冰醋酸,配成质量分数为1w/v%的醋酸水溶液,称取一定质量CS/SA(10/2)粉末加入到醋酸水溶液中,配置成1w/v%的混合溶液,用磁力搅拌器搅拌使其充分溶解,得到均一稳定的溶液。(1) Weigh a certain amount of glacial acetic acid with an electronic balance to make an acetic acid aqueous solution with a mass fraction of 1w/v%, weigh a certain mass of CS/SA (10/2) powder and add it to the acetic acid aqueous solution to form a 1w /v% mixed solution, stir it with a magnetic stirrer to fully dissolve it, and obtain a uniform and stable solution.
(2)依次向上述混合溶液中加入丙烯酰胺单体,将混合溶液在室温下搅拌2d直至溶液溶解均匀;然后逐步加入N,N’-亚甲基双丙烯酰、硫酸钙作为交联剂,过硫酸胺和N,N,N’ N’-四甲基乙二胺作为催化剂,在室温下继续搅拌1h,将配制好的溶液在室温下静置0.5-2h脱泡;将静置好的溶液倒入玻璃模具中,在室温下静置一晚上确保其完全反应。其中:壳聚糖和海藻酸钠混合粉末与丙烯酰胺单体的质量比为1:7,N,N’-亚甲基双丙烯酰交联剂与丙烯酰胺单体的质量比为0.0010,硫酸钙与丙烯酰胺单体的质量比为0.016,过硫酸铵与丙烯酰胺单体的质量比为0.010,N,N,N’,N’-四甲基乙二胺与丙烯酰胺单体的质量比为0.0030。(2) Add acrylamide monomers to the above mixed solution in sequence, and stir the mixed solution at room temperature for 2 days until the solution is uniformly dissolved; then gradually add N,N'-methylenebisacryloyl and calcium sulfate as cross-linking agents, Use ammonium persulfate and N,N,N' N'-tetramethylethylenediamine as a catalyst, continue to stir at room temperature for 1h, and leave the prepared solution at room temperature for 0.5-2h to defoam; The solution was poured into glass molds and left overnight at room temperature to ensure complete reaction. Among them: the mass ratio of chitosan and sodium alginate mixed powder to acrylamide monomer is 1:7, the mass ratio of N,N'-methylenebisacryloyl crosslinking agent to acrylamide monomer is 0.0010, sulfuric acid The mass ratio of calcium to acrylamide monomer is 0.016, the mass ratio of ammonium persulfate to acrylamide monomer is 0.010, and the mass ratio of N,N,N',N'-tetramethylethylenediamine to acrylamide monomer is 0.0030.
(3)将制备好的水凝胶完全浸泡在浓度为0.5M的CaCl2溶液中12h,阳离子扩散进入水凝胶网络结构中,诱导壳聚糖和海藻酸钠交联,生产高强高韧性的复合水凝胶防粘连材料。(3) The prepared hydrogel was completely soaked in 0.5M CaCl 2 solution for 12 hours, the cations diffused into the hydrogel network structure, induced the cross-linking of chitosan and sodium alginate, and produced high strength and high toughness Composite hydrogel anti-adhesion material.
对制得的水凝胶进行拉伸测试,得到拉伸强度为999.8kPa;拉伸弹性模量285kPa。A tensile test was performed on the prepared hydrogel to obtain a tensile strength of 999.8 kPa; a tensile modulus of elasticity of 285 kPa.
实施例3Example 3
(1)用电子天平分别称取一定量的冰醋酸,配成质量分数为0.5w/v%的醋酸水溶液,称取一定质量CS/SA(9/3)粉末加入到醋酸水溶液中,配置成1w/v%的混合溶液,用磁力搅拌器搅拌使其充分溶解,得到均一稳定的溶液。(1) Weigh a certain amount of glacial acetic acid with an electronic balance to make an acetic acid aqueous solution with a mass fraction of 0.5w/v%, weigh a certain mass of CS/SA (9/3) powder and add it to the acetic acid aqueous solution to configure 1w/v% mixed solution, stirred with a magnetic stirrer to fully dissolve, to obtain a uniform and stable solution.
(2)依次向上述混合溶液中加入丙烯酰胺单体,将混合溶液在室温下搅拌2d直至溶液溶解均匀;然后逐步加入N,N’-亚甲基双丙烯酰、硫酸钙作为交联剂,过硫酸胺和N,N,N’ N’-四甲基乙二胺作为催化剂,在室温下继续搅拌1.5h,将配制好的溶液在室温下静置0.5-2h脱泡;将静置好的溶液倒入玻璃模具中,在室温下静置一晚上确保其完全反应。壳聚糖和海藻酸钠混合粉末与丙烯酰胺单体的质量比为1:8,N,N’-亚甲基双丙烯酰交联剂与丙烯酰胺单体的质量比为0.0012,硫酸钙与丙烯酰胺单体的质量比为0.016,过硫酸铵与丙烯酰胺单体的质量比为0.012,N,N,N’,N’-四甲基乙二胺与丙烯酰胺单体的质量比为0.0035。(2) Add acrylamide monomers to the above mixed solution in sequence, and stir the mixed solution at room temperature for 2 days until the solution is uniformly dissolved; then gradually add N,N'-methylenebisacryloyl and calcium sulfate as cross-linking agents, Use ammonium persulfate and N,N,N' N'-tetramethylethylenediamine as a catalyst, continue to stir at room temperature for 1.5h, and leave the prepared solution at room temperature for 0.5-2h to defoam; The solution was poured into glass molds and left overnight at room temperature to ensure complete reaction. The mass ratio of chitosan and sodium alginate mixed powder to acrylamide monomer is 1:8, the mass ratio of N,N'-methylenebisacryloyl crosslinking agent to acrylamide monomer is 0.0012, calcium sulfate and The mass ratio of acrylamide monomer is 0.016, the mass ratio of ammonium persulfate to acrylamide monomer is 0.012, and the mass ratio of N,N,N',N'-tetramethylethylenediamine to acrylamide monomer is 0.0035 .
(3)将制备好的水凝胶完全浸泡在浓度为1M的CaCl2溶液中12h,阳离子扩散进入水凝胶网络结构中,诱导壳聚糖和海藻酸钠交联,生产高强高韧性的复合水凝胶防粘连材料。(3) The prepared hydrogel was completely soaked in 1M CaCl 2 solution for 12 hours, the cations diffused into the hydrogel network structure, induced the cross-linking of chitosan and sodium alginate, and produced a high-strength and high-toughness composite Hydrogel anti-adhesion material.
对制得的水凝胶进行拉伸测试,得到拉伸强度为1166.5kPa;拉伸弹性模量190.5kPa。A tensile test was performed on the prepared hydrogel, and the tensile strength was 1166.5 kPa; the tensile elastic modulus was 190.5 kPa.
实施例4Example 4
(1)用电子天平分别称取一定量的冰醋酸,配成质量分数为1.5w/v%的醋酸水溶液,称取一定质量CS/SA(10/2)粉末加入到醋酸水溶液中,配置成1.5w/v%的混合溶液,用磁力搅拌器搅拌使其充分溶解,得到均一稳定的溶液。(1) Weigh a certain amount of glacial acetic acid with an electronic balance to make an acetic acid aqueous solution with a mass fraction of 1.5w/v%, weigh a certain mass of CS/SA (10/2) powder and add it to the acetic acid aqueous solution to prepare The mixed solution of 1.5w/v% was stirred with a magnetic stirrer to fully dissolve it to obtain a uniform and stable solution.
(2)依次向上述混合溶液中加入丙烯酰胺单体,将混合溶液在室温下搅拌2d直至溶液溶解均匀;然后逐步加入N,N’-亚甲基双丙烯酰、硫酸钙作为交联剂,过硫酸胺和N,N,N’ N’-四甲基乙二胺作为催化剂,在室温下继续搅拌1.5h,将配制好的溶液在室温下静置0.5-2h脱泡;将静置好的溶液倒入玻璃模具中,在室温下静置一晚上确保其完全反应。其中:壳聚糖和海藻酸钠混合粉末与丙烯酰胺单体的质量比为1:10,N,N’-亚甲基双丙烯酰交联剂与丙烯酰胺单体的质量比为0.0018,硫酸钙与丙烯酰胺单体的质量比为0.016,过硫酸铵与丙烯酰胺单体的质量比为0.018,N,N,N’,N’-四甲基乙二胺与丙烯酰胺单体的质量比为0.0025。(2) Add acrylamide monomers to the above mixed solution in sequence, and stir the mixed solution at room temperature for 2 days until the solution is uniformly dissolved; then gradually add N,N'-methylenebisacryloyl and calcium sulfate as cross-linking agents, Use ammonium persulfate and N,N,N' N'-tetramethylethylenediamine as a catalyst, continue to stir at room temperature for 1.5h, and leave the prepared solution at room temperature for 0.5-2h to defoam; The solution was poured into glass molds and left overnight at room temperature to ensure complete reaction. Among them: the mass ratio of chitosan and sodium alginate mixed powder to acrylamide monomer is 1:10, the mass ratio of N,N'-methylenebisacryloyl crosslinking agent to acrylamide monomer is 0.0018, sulfuric acid The mass ratio of calcium to acrylamide monomer is 0.016, the mass ratio of ammonium persulfate to acrylamide monomer is 0.018, and the mass ratio of N,N,N',N'-tetramethylethylenediamine to acrylamide monomer is 0.0025.
(3)将制备好的水凝胶完全浸泡在浓度为1M的CaCl2溶液中12h,阳离子扩散进入水凝胶网络结构中,诱导壳聚糖和海藻酸钠交联,生产高强高韧性的复合水凝胶防粘连材料。(3) The prepared hydrogel was completely soaked in 1M CaCl 2 solution for 12 hours, the cations diffused into the hydrogel network structure, induced the cross-linking of chitosan and sodium alginate, and produced a high-strength and high-toughness composite Hydrogel anti-adhesion material.
对制得的水凝胶进行拉伸测试,得到拉伸强度为736.5kPa;拉伸弹性模量68.5kPa。A tensile test was performed on the prepared hydrogel, and the tensile strength was 736.5 kPa; the tensile elastic modulus was 68.5 kPa.
实施例5Example 5
(1)用电子天平分别称取一定量的冰醋酸,配成质量分数为2w/v%的醋酸水溶液,称取一定质量CS/SA (8/3)粉末加入到醋酸水溶液中,配置成2w/v%的混合溶液,用磁力搅拌器搅拌使其充分溶解,得到均一稳定的溶液。(1) Weigh a certain amount of glacial acetic acid with an electronic balance to make an acetic acid aqueous solution with a mass fraction of 2w/v%, weigh a certain mass of CS/SA (8/3) powder and add it to the acetic acid aqueous solution to form a 2w /v% mixed solution, stir it with a magnetic stirrer to fully dissolve it, and obtain a uniform and stable solution.
(2)依次向上述混合溶液中加入丙烯酰胺单体,将混合溶液在室温下搅拌2d直至溶液溶解均匀;然后逐步加入N,N’-亚甲基双丙烯酰、硫酸钙作为交联剂,过硫酸胺和N,N,N’ N’-四甲基乙二胺作为催化剂,在室温下继续搅拌2h,将配制好的溶液在室温下静置0.5-2h脱泡;将静置好的溶液倒入玻璃模具中,在室温下静置一晚上确保其完全反应。其中:壳聚糖和海藻酸钠混合粉末与丙烯酰胺单体的质量比为1:10,N,N’-亚甲基双丙烯酰交联剂与丙烯酰胺单体的质量比为0.0025,硫酸钙与丙烯酰胺单体的质量比为0.016,过硫酸铵与丙烯酰胺单体的质量比为0.025,N,N,N’,N’-四甲基乙二胺与丙烯酰胺单体的质量比为0.0055。(2) Add acrylamide monomers to the above mixed solution in sequence, and stir the mixed solution at room temperature for 2 days until the solution is uniformly dissolved; then gradually add N,N'-methylenebisacryloyl and calcium sulfate as cross-linking agents, Use ammonium persulfate and N,N,N' N'-tetramethylethylenediamine as a catalyst, continue to stir at room temperature for 2h, and leave the prepared solution at room temperature for 0.5-2h to defoam; The solution was poured into glass molds and left overnight at room temperature to ensure complete reaction. Among them: the mass ratio of chitosan and sodium alginate mixed powder to acrylamide monomer is 1:10, the mass ratio of N,N'-methylenebisacryloyl crosslinking agent to acrylamide monomer is 0.0025, sulfuric acid The mass ratio of calcium to acrylamide monomer is 0.016, the mass ratio of ammonium persulfate to acrylamide monomer is 0.025, and the mass ratio of N,N,N',N'-tetramethylethylenediamine to acrylamide monomer is 0.0055.
(3)将制备好的水凝胶完全浸泡在浓度为1M的CaCl2溶液中24h,阳离子扩散进入水凝胶网络结构中,诱导壳聚糖和海藻酸钠交联,生产高强高韧性的复合水凝胶防粘连材料。(3) The prepared hydrogel was completely immersed in 1M CaCl 2 solution for 24 hours, the cations diffused into the hydrogel network structure, induced the cross-linking of chitosan and sodium alginate, and produced a composite with high strength and high toughness. Hydrogel anti-adhesion material.
对制得的水凝胶进行拉伸测试,得到拉伸强度为683.7kPa;拉伸弹性模量78.7kPa。A tensile test was performed on the prepared hydrogel, and the tensile strength was 683.7kPa; the tensile elastic modulus was 78.7kPa.
以上实施例中所用的壳聚糖(CS)为乳白色粉末,脱乙酰度>70%,级别为医用级。所述的海藻酸钠(SA)为白色粉末,级别为医用级。Chitosan (CS) used in the above examples is a milky white powder with a degree of deacetylation>70%, and the grade is medical grade. Described sodium alginate (SA) is white powder, grade is medical grade.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510598128.7A CN105194740B (en) | 2015-09-20 | 2015-09-20 | A kind of post-operation adhesion preventing hydrogel and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510598128.7A CN105194740B (en) | 2015-09-20 | 2015-09-20 | A kind of post-operation adhesion preventing hydrogel and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105194740A CN105194740A (en) | 2015-12-30 |
CN105194740B true CN105194740B (en) | 2018-06-26 |
Family
ID=54942912
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510598128.7A Expired - Fee Related CN105194740B (en) | 2015-09-20 | 2015-09-20 | A kind of post-operation adhesion preventing hydrogel and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105194740B (en) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA3064403C (en) | 2010-10-01 | 2022-06-21 | Applied Medical Resources Corporation | Portable laparoscopic trainer |
US9218753B2 (en) | 2011-10-21 | 2015-12-22 | Applied Medical Resources Corporation | Simulated tissue structure for surgical training |
JP2015503961A (en) | 2011-12-20 | 2015-02-05 | アプライド メディカル リソーシーズ コーポレイション | Advanced surgery simulation |
EP2907125B1 (en) | 2012-09-26 | 2017-08-02 | Applied Medical Resources Corporation | Surgical training model for laparoscopic procedures |
US10679520B2 (en) | 2012-09-27 | 2020-06-09 | Applied Medical Resources Corporation | Surgical training model for laparoscopic procedures |
CA2885302C (en) | 2012-09-27 | 2022-08-02 | Applied Medical Resources Corporation | Surgical training model for laparoscopic procedures |
KR102537277B1 (en) | 2013-03-01 | 2023-05-30 | 어플라이드 메디컬 리소시스 코포레이션 | Advanced surgical simulation constructions and methods |
EP4170633A1 (en) | 2013-06-18 | 2023-04-26 | Applied Medical Resources Corporation | Gallbladder model |
US10198966B2 (en) | 2013-07-24 | 2019-02-05 | Applied Medical Resources Corporation | Advanced first entry model for surgical simulation |
EP3410421A1 (en) | 2013-07-24 | 2018-12-05 | Applied Medical Resources Corporation | First entry model |
EP3123460B1 (en) | 2014-03-26 | 2021-08-25 | Applied Medical Resources Corporation | Simulated dissectible tissue |
KR102615540B1 (en) | 2014-11-13 | 2023-12-19 | 어플라이드 메디컬 리소시스 코포레이션 | Simulated tissue models and methods |
ES2732722T3 (en) | 2015-02-19 | 2019-11-25 | Applied Med Resources | Simulated tissue structures and methods |
AU2016260331A1 (en) | 2015-05-14 | 2017-08-17 | Applied Medical Resources Corporation | Synthetic tissue structures for electrosurgical training and simulation |
ES2925028T3 (en) | 2015-06-09 | 2022-10-13 | Applied Med Resources | hysterectomy model |
EP3748610A1 (en) | 2015-07-16 | 2020-12-09 | Applied Medical Resources Corporation | Simulated dissectable tissue |
JP6862413B2 (en) | 2015-07-22 | 2021-04-21 | アプライド メディカル リソーシーズ コーポレイション | Appendectomy model |
ES2962620T3 (en) | 2015-10-02 | 2024-03-20 | Applied Med Resources | Hysterectomy model |
KR102757131B1 (en) | 2015-11-20 | 2025-01-20 | 어플라이드 메디컬 리소시스 코포레이션 | Simulated exciseable tissue |
CA3028980A1 (en) | 2016-06-27 | 2018-01-04 | Applied Medical Resources Corporaton | Simulated abdominal wall |
WO2018152122A1 (en) | 2017-02-14 | 2018-08-23 | Applied Medical Resources Corporation | Laparoscopic training system |
US10847057B2 (en) | 2017-02-23 | 2020-11-24 | Applied Medical Resources Corporation | Synthetic tissue structures for electrosurgical training and simulation |
US11623029B2 (en) * | 2017-04-06 | 2023-04-11 | Luna Labs Usa, Llc | Sprayable barrier and methods for prevention of postoperative adhesions |
CN107519541B (en) * | 2017-08-21 | 2021-01-01 | 上海鹏冠生物医药科技有限公司 | Hydrogel for preventing postoperative adhesion of abdominal cavity and preparation method and application thereof |
CN109394734A (en) * | 2018-09-11 | 2019-03-01 | 杭州美善明康生物科技有限责任公司 | Except the preparation method of the solid skin sticker of scar |
CN109675092B (en) * | 2018-12-17 | 2021-09-10 | 西北工业大学 | Multifunctional hydrogel adhesive suitable for high-strength bonding of dynamic tissue surface and preparation method thereof |
CN109701088B (en) * | 2018-12-19 | 2021-12-21 | 广州润虹医药科技股份有限公司 | Antibacterial and anti-inflammatory hernia repair patch and preparation method thereof |
CN111481735A (en) * | 2019-01-25 | 2020-08-04 | 华中科技大学同济医学院附属协和医院 | Medical antibacterial wound-protecting hydrogel dressing and preparation method thereof |
CN110448727B (en) * | 2019-09-17 | 2021-10-19 | 南通大学 | A kind of viscous hydrogel material, suture-free artificial nerve conduit and preparation method thereof |
CN111729123A (en) * | 2020-06-29 | 2020-10-02 | 苏州凝智新材料发展有限公司 | Suture-free hydrogel adhesive plaster for tissue wound closure and preparation method thereof |
CN112316219B (en) * | 2020-09-29 | 2022-05-10 | 浙江大学 | An anti-adhesion hydrogel-silk scaffold composite membrane and its preparation and application |
CN113491794A (en) * | 2021-04-16 | 2021-10-12 | 中国医学科学院北京协和医院 | Hydrogel patch for repairing dura mater spinalis defect and preparation method and application thereof |
CN113563534B (en) * | 2021-08-12 | 2022-11-15 | 深圳市第二人民医院(深圳市转化医学研究院) | A kind of composite polyacrylamide gel and its preparation method and application |
CN113577400B (en) * | 2021-08-16 | 2022-08-02 | 青岛琛蓝海洋生物工程有限公司 | Preparation method of marine plant polysaccharide anti-adhesion material |
CN114209891B (en) * | 2021-12-17 | 2023-02-28 | 福州大学 | A kind of super lubricating hydrogel coating of wet state adhesion and preparation method thereof |
CN115245812A (en) * | 2022-01-02 | 2022-10-28 | 华东理工大学 | Preparation method of chitosan/sodium alginate/acrylamide composite hydrogel |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103224679A (en) * | 2013-05-09 | 2013-07-31 | 重庆大学 | Chitosan polyacrylamide hydrogel base material and preparation method thereof |
CN103396562A (en) * | 2013-07-09 | 2013-11-20 | 西安交通大学 | Preparation method for sodium alginate-acrylamide-based hydrogel |
CN103469365A (en) * | 2013-09-22 | 2013-12-25 | 山东颐诺生物科技有限公司 | Alginic acid-chitosan composite fiber for tranma repairing and preparation method thereof |
CN104874029A (en) * | 2015-03-30 | 2015-09-02 | 陕西佰傲再生医学有限公司 | Hemostatic non-viscous material and preparation method thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101360942B1 (en) * | 2012-10-08 | 2014-02-12 | 조선대학교산학협력단 | Cell-laden biocompatible polymer-natural biocompatible material hybrid scaffold and producing method therof |
-
2015
- 2015-09-20 CN CN201510598128.7A patent/CN105194740B/en not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103224679A (en) * | 2013-05-09 | 2013-07-31 | 重庆大学 | Chitosan polyacrylamide hydrogel base material and preparation method thereof |
CN103396562A (en) * | 2013-07-09 | 2013-11-20 | 西安交通大学 | Preparation method for sodium alginate-acrylamide-based hydrogel |
CN103469365A (en) * | 2013-09-22 | 2013-12-25 | 山东颐诺生物科技有限公司 | Alginic acid-chitosan composite fiber for tranma repairing and preparation method thereof |
CN104874029A (en) * | 2015-03-30 | 2015-09-02 | 陕西佰傲再生医学有限公司 | Hemostatic non-viscous material and preparation method thereof |
Non-Patent Citations (1)
Title |
---|
海藻酸钠/壳聚糖复合凝胶的制备与细胞毒性评价;张林朴等;《中国组织工程研究》;20140521;第18卷(第21期);摘要、第3311页左栏第1段至第3314页右栏第3段 * |
Also Published As
Publication number | Publication date |
---|---|
CN105194740A (en) | 2015-12-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105194740B (en) | A kind of post-operation adhesion preventing hydrogel and preparation method thereof | |
Liu et al. | A highly-stretchable and adhesive hydrogel for noninvasive joint wound closure driven by hydrogen bonds | |
Chen et al. | Antibacterial adhesive self-healing hydrogels to promote diabetic wound healing | |
KR102469682B1 (en) | Formulation for repairing biological damage or hemostasis and method therefor | |
CN108912352A (en) | A kind of antibacterial adherency injection aquagel dressing and its preparation method and application | |
US9642933B2 (en) | Compositions comprising bioadhesives and methods of making the same | |
Liu et al. | Ultra-stretchable, tissue-adhesive, shape-adaptive, self-healing, on-demand removable hydrogel dressings with multiple functions for infected wound healing in regions of high mobility | |
CN108976317A (en) | A kind of chitosan biological macromolecular and its preparation method and application | |
WO2007103208A2 (en) | Biodegradable foam | |
ES2875098T3 (en) | High efficiency hemostatic adhesive polymer scaffold | |
CN109529101B (en) | Rapidly degradable strong and tough hydrogel wound dressing and preparation method thereof | |
CN113368312B (en) | Preparation method and application of biodegradable self-adhesive hydrogel | |
Cao et al. | Photo-crosslinked enhanced double-network hydrogels based on modified gelatin and oxidized sodium alginate for diabetic wound healing | |
CN112023109B (en) | Self-repairing hemostatic film capable of being adhered and preparation method thereof | |
CN102580134A (en) | Biological and haemostatic wound dressing and preparation method thereof | |
CN112007200B (en) | Antibacterial repair-promoting hemostatic anti-adhesion membrane and preparation method thereof | |
Zhang et al. | A self-healing hydrogel wound dressing based on oxidized Bletilla striata polysaccharide and cationic gelatin for skin trauma treatment | |
CN104888265B (en) | The preparation method of temperature sensitive type collagen-based compound hemostatic gel | |
CN107261195B (en) | Preparation method and application of antibacterial biomass gel net for sports wound rehabilitation dressing | |
JP6437087B2 (en) | Heat-sensitive adhesion preventing composition and use thereof | |
CN112876597B (en) | A kind of cross-linking agent, bioadhesive and its preparation method and application | |
Zhang et al. | Self-healing, antioxidant, and antibacterial Bletilla striata polysaccharide-tannic acid dual dynamic crosslinked hydrogels for tissue adhesion and rapid hemostasis | |
Xu et al. | Engineering air-in-water emulsion as adaptable multifunctional sealant | |
CN112007201B (en) | Adhesive antibacterial hemostatic sponge and preparation method thereof | |
CN118203694A (en) | Recombinant humanized collagen gel with stable cell adhesion |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: He Jinmei Inventor after: Cheng Feng Inventor after: Li Hongbin Inventor after: Huang Yudong Inventor after: Liu Changyu Inventor after: Li Jiwei Inventor before: He Jinmei Inventor before: Cheng Feng Inventor before: Liu Changyu Inventor before: Li Jiwei Inventor before: Huang Yudong |
|
CB03 | Change of inventor or designer information | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20180626 |
|
CF01 | Termination of patent right due to non-payment of annual fee |